Literature DB >> 15015769

Increased hMSH2 protein expression in glioblastoma multiforme.

Tapasya Srivastava1, Parthaprasad Chattopadhyay, A K Mahapatra, Chitra Sarkar, Subrata Sinha.   

Abstract

hMSH2 and hMLH1 are the most commonly studied mismatch repair proteins and their absence is associated with microsatellite instability (MSI) especially in hereditary non-polyposis colorectal cancer, and also in some sporadic tumors. However, there are some tumors, namely, urothelial neoplasms and salivary gland tumors, where overexpression of the proteins has been reported, though the implications of these findings are not very clear. There is no report on the expression of these proteins in different grades of human astrocytic tumors. We have studied the expression pattern of hMSH2 and hMLHI in high (Grade IV, glioblastoma multiforme (GBM)) and low (Grade II, astrocytoma (AS)) grade primary human gliomas by immunohistochemistry. We observed that there was a significantly higher expression of hMSH2 protein in 28 GBM (mean 703.07 +/- 236.28) as compared with 27 AS (mean 307.03 +/- 204.71), p = 1.47 x 10(-8) by a two-tailed t-test of unpaired samples. However, for hMLH1 no such difference was observed, mean counts being 543.29 +/- 320.35 for 27 GBM and 505.92 +/- 342.37 for 26 AS, p = 0.67. A small proportion of tumors was observed to be immunonegative for either of the proteins in both high- and low-grade tumors. While MSI has been shown previously to be infrequent in human astrocytic tumors, the implications of the overexpression of hMSH2 in GBM are not clear.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15015769     DOI: 10.1023/b:neon.0000013482.99032.b0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Germline hMSH2 and differential somatic mutations in patients with Turcot's syndrome.

Authors:  T L Chan; S T Yuen; L P Chung; J W Ho; K Kwan; Y W Fan; A S Chan; S Y Leung
Journal:  Genes Chromosomes Cancer       Date:  1999-06       Impact factor: 5.006

2.  Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.

Authors:  Q Wei; M L Bondy; L Mao; Y Gaun; L Cheng; J Cunningham; Y Fan; J M Bruner; W K Yung; V A Levin; A P Kyritsis
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

3.  hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage.

Authors:  D R Duckett; S M Bronstein; Y Taya; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Microsatellite instability is infrequent in sporadic adult gliomas.

Authors:  D A Lundin; A Blank; M S Berger; J R Silber
Journal:  Oncol Res       Date:  1998       Impact factor: 5.574

5.  Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.

Authors:  Atia A Hamid; Masaki Mandai; Ikuo Konishi; Kanako Nanbu; Yuko Tsuruta; Takashi Kusakari; Masatoshi Kariya; Masato Kita; Shingo Fujii
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

6.  Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.

Authors:  H Haapasalo; J Isola; P Sallinen; H Kalimo; H Helin; I Rantala
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Expression of the p53 protein in a spectrum of astrocytic tumours.

Authors:  D W Ellison; K C Gatter; P V Steart; D P Lane; R O Weller
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

8.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Authors:  F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

Review 9.  Instability of microsatellites in human gliomas.

Authors:  E Dams; E J Van de Kelft; J J Martin; J Verlooy; P J Willems
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

10.  Microsatellite instability in primary and metastatic colorectal cancers.

Authors:  G Ishimaru; J Adachi; M Shiseki; N Yamaguchi; T Muto; J Yokota
Journal:  Int J Cancer       Date:  1995-06-22       Impact factor: 7.396

View more
  9 in total

1.  Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas.

Authors:  Mahmoud R Hussein; Rabab M H El-Ghorori; Yasser G Abd El-Rahman
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

2.  Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors.

Authors:  Tapasya Srivastava; Kunzang Chosdol; Parthaprasad Chattopadhayay; Chitra Sarkar; Ashok K Mahapatra; Subrata Sinha
Journal:  J Neurooncol       Date:  2006-10-04       Impact factor: 4.130

3.  Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.

Authors:  Maximilian Burger; Stefan Denzinger; Christine G Hammerschmied; Andrea Tannapfel; Ellen C Obermann; Wolf F Wieland; Arndt Hartmann; Robert Stoehr
Journal:  J Mol Med (Berl)       Date:  2006-08-03       Impact factor: 4.599

4.  Ectopic expression of human MutS homologue 2 on renal carcinoma cells is induced by oxidative stress with interleukin-18 promotion via p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) signaling pathways.

Authors:  Chen Mo; Yumei Dai; Ning Kang; Lianxian Cui; Wei He
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

Review 5.  The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer.

Authors:  Markus Seifert; Jörg Reichrath
Journal:  J Mol Histol       Date:  2006-11-02       Impact factor: 2.611

6.  Integrated analysis of mismatch repair system in malignant astrocytomas.

Authors:  Irene Rodríguez-Hernández; Juan Luis Garcia; Angel Santos-Briz; Aurelio Hernández-Laín; Jose María González-Valero; Juan Antonio Gómez-Moreta; Oscar Toldos-González; Juan Jesús Cruz; Javier Martin-Vallejo; Rogelio González-Sarmiento
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

7.  Topoisomerase IIβ mediates the resistance of glioblastoma stem cells to replication stress-inducing drugs.

Authors:  Saša Kenig; Valentina Faoro; Evgenia Bourkoula; Neža Podergajs; Tamara Ius; Marco Vindigni; Miran Skrap; Tamara Lah; Daniela Cesselli; Paola Storici; Alessandro Vindigni
Journal:  Cancer Cell Int       Date:  2016-07-26       Impact factor: 5.722

8.  Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC).

Authors:  Xueru Zhu; Yiwei Wang; Hongjia Li; Wenji Xue; Ruifen Wang; Lifeng Wang; Meiling Zhu; Leizhen Zheng
Journal:  J Cancer       Date:  2017-06-01       Impact factor: 4.207

9.  Atorvastatin Enhances Effects of Radiotherapy on Prostate Cancer Cells and Xenograft Tumor Mice Through Triggering Interaction Between Bcl-2 and MSH2.

Authors:  Zhenhua He; Jingmin Yuan; Fuhui Shen; Fangang Zeng; Ping Qi; Zhiping Wang; Zhenxing Zhai
Journal:  Med Sci Monit       Date:  2020-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.